메뉴 건너뛰기




Volumn 165, Issue 2, 2011, Pages 375-382

Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; ETRETIN; METHOTREXATE;

EID: 79960621034     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10329.x     Document Type: Article
Times cited : (23)

References (18)
  • 1
    • 77957656300 scopus 로고    scopus 로고
    • A practical approach to monitoring patients on biological agents for the treatment of psoriasis
    • Emer JJ, Frankel A, Zeichner JA,. A practical approach to monitoring patients on biological agents for the treatment of psoriasis. J Clin Aesthet Dermatol 2010; 3: 20-6.
    • (2010) J Clin Aesthet Dermatol , vol.3 , pp. 20-26
    • Emer, J.J.1    Frankel, A.2    Zeichner, J.A.3
  • 2
    • 43249114046 scopus 로고    scopus 로고
    • To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis
    • Huang W, Cordoro KM, Taylor SL, et al. To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis. J Am Acad Dermatol 2008; 58: 970-7.
    • (2008) J Am Acad Dermatol , vol.58 , pp. 970-977
    • Huang, W.1    Cordoro, K.M.2    Taylor, S.L.3
  • 4
    • 77951594760 scopus 로고    scopus 로고
    • The treatment of moderate-to-severe psoriasis: Prescreening and monitoring psoriatic patients on biologics
    • Levine D, Strober BE,. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics. Semin Cutan Med Surg 2010; 29: 28-34.
    • (2010) Semin Cutan Med Surg , vol.29 , pp. 28-34
    • Levine, D.1    Strober, B.E.2
  • 6
    • 49849097373 scopus 로고    scopus 로고
    • Monitoring biologics for the treatment of psoriasis
    • Papp KA,. Monitoring biologics for the treatment of psoriasis. Clin Dermatol 2008; 26: 515-21.
    • (2008) Clin Dermatol , vol.26 , pp. 515-521
    • Papp, K.A.1
  • 7
    • 70249137988 scopus 로고    scopus 로고
    • European S3-guidelines on the systemic treatment of psoriasis vulgaris
    • Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 (Suppl. 2): 1-70.
    • (2009) J Eur Acad Dermatol Venereol , vol.23 , Issue.SUPPL. 2 , pp. 1-70
    • Pathirana, D.1    Ormerod, A.D.2    Saiag, P.3
  • 8
    • 71949087471 scopus 로고    scopus 로고
    • British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009
    • Smith CH, Anstey AV, Barker JN, et al. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009; 161: 987-1019.
    • (2009) Br J Dermatol , vol.161 , pp. 987-1019
    • Smith, C.H.1    Anstey, A.V.2    Barker, J.N.3
  • 9
    • 0018099294 scopus 로고
    • Severe psoriasis - oral therapy with a new retinoid
    • Fredriksson T, Pettersson U,. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44. (Pubitemid 8387357)
    • (1978) Dermatologica , vol.157 , Issue.4 , pp. 238-244
    • Fredriksson, T.1    Pettersson, U.2
  • 10
    • 84871774938 scopus 로고    scopus 로고
    • National Cancer Institute Published June 14, 2010. Available at: (last accessed 4 May 2011)
    • National Cancer Institute. Common Terminology Criteria for Adverse Events-version 4.03. Published June 14, 2010. Available at: (last accessed 4 May 2011).
    • Common Terminology Criteria for Adverse Events - Version 4.03
  • 11
    • 77953097470 scopus 로고    scopus 로고
    • Neutropenia in patients receiving anti-tumor necrosis factor therapy
    • Hastings R, Ding T, Butt S, et al. Neutropenia in patients receiving anti-tumor necrosis factor therapy. Arthritis Care Res (Hoboken) 2010; 62: 764-9.
    • (2010) Arthritis Care Res (Hoboken) , vol.62 , pp. 764-769
    • Hastings, R.1    Ding, T.2    Butt, S.3
  • 14
    • 77956049370 scopus 로고    scopus 로고
    • Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis
    • Sokolove J, Strand V, Greenberg JD, et al. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1612-17.
    • (2010) Ann Rheum Dis , vol.69 , pp. 1612-1617
    • Sokolove, J.1    Strand, V.2    Greenberg, J.D.3
  • 15
    • 77953197048 scopus 로고    scopus 로고
    • C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy
    • Coimbra S, Oliveira H, Reis F, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 789-96.
    • (2010) J Eur Acad Dermatol Venereol , vol.24 , pp. 789-796
    • Coimbra, S.1    Oliveira, H.2    Reis, F.3
  • 18
    • 77949797498 scopus 로고    scopus 로고
    • Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: A retrospective, observational study
    • Pink AE, Fonia A, Allen MH, et al. Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study. Br J Dermatol 2010; 162: 780-5.
    • (2010) Br J Dermatol , vol.162 , pp. 780-785
    • Pink, A.E.1    Fonia, A.2    Allen, M.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.